Executive Director, Global Marketing

Kymera Therapeutics•Watertown, MA

8h•$245,000 - $335,000

About The Position

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. As we prepare for the potential launch of KT-621, a novel oral protein degrader being developed for immune-mediated diseases, we are seeking an experienced and strategic commercial leader to lead Global Marketing and Commercial Launch Readiness. The Executive Director, Global Marketing – KT-621 will be responsible for leading global commercial strategy, launch readiness, and brand planning activities for KT-621. Reporting directly to the Chief Commercial Officer, this individual will play a pivotal leadership role in shaping the commercial vision, product positioning, customer strategy, and launch preparation for one of the most important assets in Kymera's portfolio.

Requirements

Advanced degree required (MBA, PharmD, PhD, MD, MPH, or equivalent).
15+ years of progressive pharmaceutical or biotechnology commercial experience spanning global and U.S. markets.
Significant experience in global marketing, commercial strategy, and launch planning.
Direct immunology experience required.
Direct atopic dermatitis experience required.
Demonstrated success leading products through late-stage development and US commercial launch.
Strong understanding of specialty physician markets, payer dynamics, and patient journeys.
Strategic thinker with strong commercial acumen
Exceptional communication and executive presence
Proven ability to influence cross-functional teams
Data-driven decision maker
Strong team builder and talent developer
Results-oriented with a demonstrated ability to execute

Nice To Haves

Asthma experience strongly preferred.

Responsibilities

Lead development and execution of the global commercial strategy for KT-621 from late-stage development through launch and lifecycle management.
Define the global product vision, positioning, differentiation, target patient segments, and value proposition.
Lead global launch readiness planning and commercialization activities.
Develop disease-state and product-specific marketing strategies and messaging.
Partner closely with the Analytics & Insights function on competitive intelligence, market assessments, forecasting inputs, and customer research.
Serve as the commercial lead within cross-functional development teams.
Influence clinical development strategy, endpoint selection, and evidence-generation plans.
Evaluate expansion opportunities across immunology indications.
Build strong partnerships across Clinical Development, Medical Affairs, Market Access, Regulatory, Finance, and Executive Leadership.